Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | TRIM58 | Q8NG06 | 3/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31501699 | 0.92 | HRH4 (0.40) | MAOBHTR6TSHRMCHR1PIM1 | |
| SCHEMBL31501683 | 0.91 | NPY5R (0.39) | HTR6TSHRMCHR1PIM1TRIM58 | |
| SCHEMBL31501704 | 0.83 | HRH4 (0.43) | TSHRMCHR1PIM1NPY5RTLR7 | |
| SCHEMBL25222339 | 0.81 | HTT (0.44) | TSHRALDH1A1HSD17B10CYP1A2CYP2D6 | |
| SCHEMBL30455740 | 0.81 | HTT (0.44) | TSHRALDH1A1HSD17B10CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL25278259 | 0.80 | HTT (0.43) | TSHRALDH1A1HSD17B10CYP1A2CYP2D6 | |
| SCHEMBL31501684 | 0.79 | TSHR (0.48) | MAOBHTR6TSHRNPY5RALDH1A1 | |
| SCHEMBL31501603 | 0.77 | MEN1 (0.41) | CTNNB1TCF7L2MEN1 | |
| SCHEMBL25421902 | 0.76 | TSHR (0.36) | MAOBHTR6TSHRMCHR1PIM1 | |
| SCHEMBL31501657 | 0.75 | MEN1 (0.45) | CTNNB1TCF7L2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066358-A1 | Inhibitors of Menin-MLL Interaction | BALA THERAPEUTICS, INC. | 2025-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066358-A1 | Inhibitors of Menin-MLL Interaction | MLLT1, MEN1, BMI1 | MAOB 3541/4885HTR6 4128/4885TSHR 4606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.